Embedded Files
Pleroo is the Greek word for "fullness", "to fulfill" or "to complete". For "Pleroo Research", it signifies our importance of achieving its mission to contribute to science and humanity by a deliberate intention to serve, excel in knowledge skill with strong virtues of a "sound mind" and purpose.
Pleroo Research operates from Bangalore, India.
Mission
Our mission is to bring you the best of scientific expertise and analytical approach to your research programs enabling you to move faster towards your objective. We understand your objectives and work alongside bringing in new perspectives, early evaluations and designs enabling strategic decision making. We would thus play our part in promoting innovation, new ventures and independent thinking.
We value
Your objectives and anticipated outcomes
Innovative and methodical approach to challenges
Integrity and safety of data
Your time
Your rightful need to be informed at every step
Team Pleroo Research
Team Pleroo Research
Biju Benjamin Ph.D
Dr. Biju Benjamin is a Scientist-Entrepreneur with a passion for novel technologies and a mission for well-being. A strong advocate of cross functional applications like mathematical approaches in biology for discovery and clinical development of new drugs or life changing solutions. He is also technology enthusiast.
Dr. Benjamin has his core expertise in DMPK, Clinical Pharmacology and mathematical modelling with a sound background of Pharmaceutical Sciences and Pharmacology. He brings along a balanced blend of experimental, data analysis and mathematical modelling applied to Drug discovery and Clinical Development during his career, covering therapeutic areas of cancer, diabetes, anti-infectives, inflammation, allergy, immunology, and CNS disorders. A rich wet lab research experience spanning over a decade complemented by translational research and mathematical modelling experience applied to clinical development providing an end-to-end visibility of drug discovery and clinical development process.
Dr. Benjamin led the ADME and PK-PD functions being part of ‘early development engine’ Vanthys, a joint venture between Eli-Lilly and Jubilant (Vanthys), and various functional roles in drug discovery with leading Indian research companies Ranbaxy and Dr. Reddys. In his consulting role he has held senior positions and advisory roles in various organisations
Biju Benjamin is a Ph.D from BITS, Pilani and has a Masters degree in Pharmacology from MAHE, Manipal. He is also the primary author or contributor to 16 publications or poster presentations, spanning areas of bioanalysis, pharmacology and pharmacokinetics.
Harsha Doddihal M.D
Dr Harsha Doddihal is a healthcare, life science and pharmaceutical professional with entrepreneurial DNA. He is a highly accomplished leader with extensive experience and a proven track record of success in the pharmaceutical industry, specialising in oncology and immunology. Harsha brings a wide experience in overseeing clinical development processes, achieving cost efficiencies in clinical trials, and ensuring regulatory compliance. He has been leadership positions directing cross-functional teams to consistently accomplish organisational objectives and is an expert in regulatory submissions and stakeholder engagement, ensuring compliance with global regulatory standards.
Dr Harsha is a Board Certified Radiation Oncologist and is an Executive MBA candidate from IMD, Lausanne. He has certifications in Operations Management, Finance and Entrepreneurship from US universities.
Harsha Co-founded a company in digital health and home health care. The company works to enhance healthcare accessibility for the elderly population, utilizing technology effectively to simplify health navigation and encourage wellness. Harsha has demonstrating strong leadership in growth strategies, digital health initiatives, talent acquisition, and meticulous patient services monitoring.
In his past roles he has played a key role in making marketing decisions, building partnerships, and developing innovative healthcare services.
Harsha is the Lead clinical consultant with focus on Oncology area as well as development of NCE, Bispecifics, Trispecifics or speciality products in clinical domain.
Darshan Bhatt M.D
Dr. Darshan spent 10 years with AstraZeneca in his roles providing strategic inputs to drug discovery and development in India and UK. At AstraZeneca UK, as the Global Drug Safety Physician he was member of Clinical Development Teams for Cardiovascular and Inflammation therapy areas in First in Man studies to Phase III program. He represented the company at the FDA and EMEA to discuss the End of Phase II program and design of Phase III study in development of Ticagrelor.
In 2007 Darshan was part of the team that set up Sciformix Technologies, a service provider in Clinical Data Management, Biostatistics and Medical Writing. In 2010, Darshan was involved in the due diligence process and development of new pharmaceutical and biological products at Vanthys Pharmaceutical Development Pvt. Ltd.
Darshan Bhatt is a postgraduate in medicine and holds an M.Phil. degree in Hospitals and Health Systems Management. Darshan has chaired the Data & Safety Monitoring Board for several clinical studies for different clients.
Page updated
Report abuse